See below for funding opportunities for researchers to enhance their programs through pilot grants, travel grants for conferences, and skill development from CAIRIBU programs and centers, along with a collection of relevant funding opportunities from national institutes, affiliated institutions, and other agencies supporting urologic research.
All CAIRIBU Funding Opportunities
The CAIRIBU U24 Interactions Core provides opportunities for trainees and investigators to advance their research programs. These include pilot grants from the George M. O’Brien Urology Cooperative Research Centers Program (U54), CAIRIBU pilot awards, and grants for travel-related expenses to attend conferences or participate in skill-development activities that will enhance their research capabilities.
U54 O’Brien Center Opportunity Pool Awards
These awards are for early-stage investigators OR established investigators not previously involved in benign genitourinary research. Awards should be integrated within the overall research goals of a current O’Brien Urology Center and, where possible, make use of existing Biomedical Cores or other resources at the parent Center
Conference and Data Dissemination Grants
CAIRIBU Conference and Data Dissemination Grants support the participation of trainees and early-stage investigators in conferences, educational meetings, workshops, and symposia by offering funds to cover travel-related expenses to these events.
Research Training and Development Grants
CAIRIBU Research Training & Development Grants support CAIRIBU-affiliated non-malignant urology researchers, including investigators, post-doctoral trainees, students, lab technicians, and research assistants by covering expenses for unique opportunities and activities that enhance skills, advance careers, and strengthen institutional programs.
CAIRIBU Collaboration Award
Recipients are awarded funding to support short-term, novel, high-risk non-malignant urologic research. CAIRIBU Collaboration Awards support proposals that engage early-stage investigators or those new to urology research, establish new collaborations and consist of highly interdisciplinary research teams.
Extramural Funding Opportunities
The CAIRIBU U24 Interactions Core collects and stores funding opportunities relevant to CAIRIBU-affiliated investigators below, including opportunities from the National Institutes of Health, CAIRIBU-affiliated institution-specific funding to support stakeholder engagement in research, and funding opportunities from other funding agencies that support non-malignant urologic research.
NIDDK Funding Announcements
Find funding announcements that support non-malignant urologic or relevant research from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Other NIH Funding Announcements
Find funding announcements that support non-malignant urologic or relevant research from the National Institutes of Health (NIH).
Recent Award Recipients
Congratulations to the 2023 CAIRIBU Collaboration Award Recipients. Recipients were awarded funding to support short-term, novel, high-risk non-malignant urologic research. CAIRIBU Collaboration Awards support proposals that engage early-stage investigators or those new to urology research, establish new collaborations, and consist of highly interdisciplinary research teams.
Ramy Goueli, MD, MHS
Dr. Goueli was awarded a CAIRIBU Collaboration award for his proposal, “Neuroendocrine cells function in the ageing human female urethra”. Dr. Goueli earned his medical degree at the Yale School of Medicine. He completed his residency in urology at NewYork-Presbyterian Hospital.
Rose Khavari, MD
Dr. Khavari received a CAIRIBU Collaboration award for her proposal, “Optimization of onabotulinumtoxinA (BTX-A) injection for the treatment of neurogenic lower urinary tract dysfunction”. Dr. Rose Khavari earned her medical doctorate degree from the University of Texas Medical Branch in Galveston, Texas.
Henry Schreiber, PhD
Dr. Schreiber received a CAIRIBU Collaboration award for his proposal, “Modeling multiple sclerosis-induced susceptibility to urinary tract infection in mice”. Dr. Schreiber received his PhD at University of Washington where he studied genetics and metagenomics of bacterial pathogenesis.